CASI PHARMACEUTICALS, INC. (CASIF) Gross profit 2020–2025
CASI PHARMACEUTICALS, INC. (CASIF) annual gross profit history from SEC filings — each fiscal year as reported.
$10.1MFY2025 · since FY2020: $5.6M → $10.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.1M | -9.6% |
| FY2024 | $11.1M | -44.4% |
| FY2023 | $20.1M | -26.5% |
| FY2022 | $27.3M | +54.9% |
| FY2021 | $17.6M | +212.6% |
| FY2020 | $5.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice